HSCS logo

HEARTSCIENCES INC

HSCSNASDAQ
🏆 #4668 by market capUS Equity
$3.11▼ $0.02 (−0.64%)
Pre-market · at close
🔔
Track HSCS
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 0.6%
7d▼ 0.6%
14d▼ 1.6%
30d▼ 24.8%
ytd▲ 4.9%
1y▲ 3.7%
🏦Market Cap
$15M
Small Cap
📈Revenue Growth (YoY)
-27.7%
Declining
📊Gross Margin
60.8%
High
💵FCF Margin
—
⚖️P/S Ratio
3606.0x
Expensive
Otter Score
—
Insufficient data

Trading Snapshot

Day Range
$3.02 – $3.16
52-Week Range
$1.63 – $5.25
Volume (shares)
4,627
Avg Volume (shares)
—
Shares Outstanding
5.0M
Next Earnings
—

Fundamentals Snapshot

Annual Revenue
$4,319
Last Q Revenue
$2,100
P/E Ratio
—
P/S Ratio
3606.0x
EPS (TTM)
$-3.21
Dividend Yield
—
Dilution (1yr)
+186.2%
HSCS logo

HEARTSCIENCES INC

HSCS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$4K▼ −0.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-2982.1%▲ +3.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$8M▲ +0.7% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$7M▲ +0.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
2.6M▲ +186.2% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$1M▼ −$74K YoY
StockOtter · stockotter.space

About HEARTSCIENCES INC

HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process. Among its offerings is the MyoVista wavECG device, a 12-lead resting ECG that provides comprehensive diagnostic information concerning cardiac function alongside conventional ECG data in a single examination. Furthermore, the company offers MyoVista Insights, a cloud-based platform capable of hosting its AI-ECG algorithms across various ECG hardware systems. Established in 2007, HeartSciences Inc. operates from its headquarters in Southlake, Texas. The company was formerly named Heart Test Laboratories, Inc. until its rebranding to HeartSciences Inc. in October 2024.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100

Analyst Ratings

ⓘ
Consensus
Buy
8 analysts
Strong Buy2
Buy5
Hold1
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

News unavailable.